A graduate of the Pharmaceutical University of Shenyang, he also has a Ph.D. in Pharmaceutical Sciences obtained at the University of Toronto. Mr. Liu is the author and co-author of numerous medical and biological publications.
Mr. Liu has broad managerial and scientific experience. He is the founder of Cogenes Biotechnology Incorporation and, as of 2011, also its CEO. He also established NovoTek Pharmaceuticals Limited (Hong Kong) and Beijing NovoTek Medicinal Technology Development Co. Ltd. (Beijing). He was the co-founder of JCS Biopolytech Incorporation, where he acted as Business Development Director from 2005 to January 2007. From November 2007 to April 2008 he was the Clinical Trial Liaison Manager at US-based Pharmaceuticals Inc., and from April 2008 to July 2009 he was the Chief Representative for China at Immtech Pharmaceuticals Inc.